Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
SOPH · against 484 other Healthcare companies of similar size
Ranked #410 of 485 · scores higher than 15% of peers · safety percentile 18
Bars: peers in each 10-point band of the safety percentile (higher = safer; 67+ earns the lower-risk grade)41 peers with a safety percentile of 10–19, including SOPH · Click a bar to see the companies
Mainly because of its debt / equity and beta, which are weaker than most Healthcare peers.
Risk is relative to the sector, not a bankruptcy probability. Banks and brokers carry high leverage by design, and share buybacks can shrink equity and current assets, which raises debt/equity on paper.
| Metric | SOPH | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Debt / equityLower is better · 452 reported | 0.74× | 0.18× | 16% | 33% | |
| BetaLower is better · 462 reported | 0.98 | 0.42 | 20% | 33% | |
| Current ratioHigher is better · 479 reported | 2.69× | 2.89× | 47% | 33% |
| Rank | Company | Market cap | Safety | Overall |
|---|---|---|---|---|
| 1 | 1.2B USD | 100 | 40 | |
| 2 | 1.1B USD | 100 | ||
| 3 | 1.0B USD | 99 | 35 | |
| 4 | 421M USD | 99 | 52 | |
| 5 | 397M USD | 99 | 37 | |
| 406 | 748M USD | 19 | 62 | |
| 407 | 21.1B ZAR (≈$1.2B) | 19 | 60 | |
| 408 | 6.7B CNY (≈$938M) | 18 | 30 | |
| 409 | 5.1B CNY (≈$709M) | 18 | 12 | |
| 410 | 588M USD | 18 | 24 | |
| 411 | 771M EUR (≈$848M) | 17 | 53 | |
| 412 | 3.5B CNY (≈$496M) | 17 | 38 | |
| 413 | 725M USD | 17 | 19 | |
| 414 | 578M USD | 17 | 22 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score